<!DOCTYPE html>
<html class="theme-cyan cdc-page-type-content cdc-2020" lang="en-us">

<head>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta charset="utf-8">

    <link rel="shortcut icon" href="favicon.ico">
    <link rel="stylesheet" href="home_files/bootstrap.css">
    <link rel="stylesheet" href="home_files/app.css">

	<title>Vaccine 1 | AstraZeneca</title>
    <meta name="description" content="">
    <meta name="keywords" content="">
</head>

<body>

    <div class="container-fluid site-title">
    <!-- <div class=""> -->
        <div class="container">
            <div class="row">
                <h3>L1-team05</h3>
            </div>
        </div>
    </div>

    <div id="cdc-meganav-wrapper">

        <div class="container" id="cdc-meganav-bar">

            <nav class="navbar navbar-expand-xl yamm">

                <ul class="nav navbar-nav nav-justified w-100">

                    <li class="nav-item" id="menu_home">
                        <a class="nav-link" href="home.html">
                            Home						</a>
                    </li>

                    <li class="nav-item" id="menu1">
                        <a class="nav-link active" href="page1.html">
                            AstraZeneca						</a>
                    </li>

                    <li class="nav-item" id="menu2">
                        <a class="nav-link" href="page2.html">
                            Pfizer-BioNTech						</a>
                    </li>

                    <li class="nav-item" id="menu3">
                        <a class="nav-link" href="page3.html">
                            Sinovac CoronaVac						</a>
                    </li>

                </ul>
            </nav>
        </div>
    </div>

    <!-- Page Content Wrap -->
    <div class="container d-flex flex-wrap body-wrapper bg-white">

        <!-- Content -->
        <main class="col-xl-9 order-xl-2">

            <div class="row">

                <div class="col content">

                    <div class="row">
                        <br>
                        <h2 id="content" class="open d-lg-block">Vaccine 1: AstraZeneca</h2>
                        <br>
                        <br>
                        <br>

                    </div>
                    <div class="cdc-2020-bar container">

                    </div>

                    <div class="syndicate">
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="card border-0 rounded-0 mb-3">
                                    <div class="card-body bg-primary">
                                        <div class="row">
                                            <div class="d-none">
                                                <div class="text-center">
                                                    <img src="home_files/clipboard.png" alt="Clipboard with checkmarks" class="card-img-top img-fluid p-0 bg-primary card-img-orig d-none d-md-block rounded-0">
                                                </div>
                                            </div>
                                            <div class="col">
                                                <h3 class="card-title h3 mb-3 text-left">General Information</h3>
                                                <p>
                                                  <b>Country of origin:</b> UK
                                                  <br><br>
                                                  <b>Total no. of doses ordered:</b> 12.8 million
                                                </p>
                                                <p>
                                                  <b>Type:</b> The AstraZeneca vaccine is a viral vector vaccine, jointly produced by UK-based pharmaceutical company AstraZeneca and Oxford University. It uses a modified virus to deliver a small portion of the virus' genetic code to the body's cells, teaching them to produce the spike protein found in the coronavirus and build an immune response to it. This vaccine must also be administered in two doses and has an efficacy rate of 62 per cent to 90 per cent.
                                                </p>

                                            </div>
                                            <div class="pl-md-0 col-md-3 d-none d-md-block">
                                                <div class="text-center">
                                                    <img src="home_files/Astra_Zeneca.jpg" alt="Clipboard with checkmarks" class="card-img-top img-fluid p-0 bg-primary card-img-orig d-none d-md-block rounded-0">
                                                </div>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="row-fluid">
                                    <div class="vc_empty_space col-12 pt-3 pb-3">
                                        <span class="vc_empty_space_inner"></span>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="color-bar cyan half">
                                    <div></div>
                                    <div></div>
                                    <div></div>
                                </div>
                                <div class="card border-0 rounded-0 mb-3">
                                    <div class="card-body ">
                                        <h2 class="card-title h3 mb-3 text-left">Malaysia - AstraZeneca</h2>
                                        <p>Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation.</p>

                                        <p>AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.</p>

                                        <p>It is one of the worldâ€™s leading pharmaceutical companies with healthcare sales of $27.97 billion. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.</p>

                                        <p>In Malaysia, we are currently one of the top pharmaceutical companies and we are committed to continued innovation, close customer relationships, people development and an ethical responsible approach to business, with an aim to make a difference to the lives of patients and the healthcare professionals.</p>

                                        <p><img src="home_files/astra_zeneca_malaysia.jpg" width="1000" height="500" alt="covid_graph"></p>

                                        <p>The countries that use AstraZeneca</p>

                                        <ul>
                                            <li>Malaysia</li>
                                            <li>Germany</li>
                                            <li>Canada</li>
                                            <li>France</li>
                                            <li>Spain</li>
                                            <li>Italy</li>
                                            <li>Norway</li>
                                            <li>Denmark</li>
                                            <li>Austria</li>
                                            <li>Sweden</li>
                                            <li>Finland</li>
                                            <li>Switzerland</li>
                                            <li>Netherlands</li>
                                            <li>Ireland</li>
                                            <li>Portugal</li>
                                            <li>Luxembourg</li>
                                            <li>Cyprus</li>
                                            <li>Latvia</li>
                                            <li>Lithuania</li>
                                            <li>Estonia</li>
                                            <li>Bulgaria</li>
                                            <li>Romania</li>
                                            <li>Iceland</li>
                                            <li>Slovenia</li>
                                        </ul>

                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row ">
                            <div class="col-md-12">
                                <div class="card border-0 rounded-0">
                                    <div class="card-body bg-quaternary">
                                        <h2 class="card-title h3 mb-3 text-left">Sub-content title</h2>
                                        <p>Sub content here...</p>

                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

          <br>
          <br>
          <br>

        </main>

    </div>

    <div class="container-fluid">
        <div class="container">

            <div class="card-body bg-quaternary">

                <h5>Disclaimer</h5>
                <p style="font-size:14px;">This website is created mainly for educational and non-commercial use only. It is a
                partial fulfillment for completion of unit SWE20001 - Development Project 1 offered in
                Swinburne University of Technology, Sarawak Campus. The web-master and author(s) do not
                represent the business entity. The content of the pages of this website might be out-dated
                or inaccurate, thus, the author(s) and web-master does not take any responsibility for
                incorrect information disseminated or cited from this website.</p>

            </div>
        </div>
    </div>

</body>
</html>
